Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-09 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |